Ireland
--:--IST
Starting soon Observational

Analgesic Strategies After Mastectomy: RIB vs RIB + DPIPB

NCT07401602 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-02-10
Last updated
2026-02-10

Condition(s) studied

Postoperative Pain

Investigational drug(s) / intervention(s)

Analgesic Strategy

Analgesic Strategy: Systemic Analgesia: Postoperative pain was managed using standard systemic analgesic medications as part of routine clinical care. Rhomboid Intercostal Block (RIB): Postoperative analgesia was provided using an ultrasound-guided rhomboid intercostal block performed as part of routine clinical practice. RIB + Deep Parasternal Intercostal Plane Block (DPIPB): Postoperative analgesia was provided using a combination of ultrasound-guided rhomboid intercostal block and deep parasternal intercostal plane block as part of routine clinical care.

Study summary

This retrospective observational study evaluates postoperative pain outcomes in patients undergoing elective mastectomy who received systemic analgesia, rhomboid intercostal block (RIB), or combined rhomboid intercostal block with deep parasternal intercostal plane block (RIB + DPIPB). Medical records from October 2024 to October 2025 will be reviewed. Primary outcomes include pain scores within the first 24 hours, with secondary outcomes including opioid consumption, additional analgesic requirements, patient satisfaction, and early postoperative complications. All data will be analyzed retrospectively and anonymously.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Female patients aged 18-70 years * Elective mastectomy performed between October 2024 and October 2025 * ASA physical status I-III * Complete postoperative pain and analgesia records for the first 24 hours * Clearly documented analgesic technique (systemic analgesia, RIB, or RIB + DPIPB) Exclusion Criteria: * Incomplete or missing medical records * Emergency mastectomy or emergency surgery * Reoperation within the first 24 hours postoperatively * Major intraoperative complications preventing standard analgesia * Neurological or psychiatric conditions interfering with pain assessment

Primary outcome measure(s)

  • Postoperative Pain Score (VAS) — Within the first 24 hours after surgery (postoperative 1, 6, 12, and 24 hours).
    Postoperative pain intensity assessed using the Visual Analog Scale (VAS) based on routinely recorded clinical data.

Trial sites (1)

FacilityCityRegionStatus
Istinye Üniversity Istanbul Merkez Mahallesi
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07401602 on ClinicalTrials.gov ↗ ← All trials in Turkey